Hydroflumethiazide + Spironolactone Tablet – Manufacturer, Supplier & PCD Franchise
Hydroflumethiazide + Spironolactone Tablet
Hydroflumethiazide + Spironolactone — PCD Pharma Franchise, Wholesale Supply & Third Party Manufacturing
Form: Tablet
Class: Fixed-Dose Combination — Thiazide diuretic + Potassium-sparing diuretic (aldosterone antagonist)
✓ Pan-India Monopoly PCD
✓ Available Now
Pricing, brochure & monopoly territory within 24 hrs.
Hydroflumethiazide + Spironolactone Tablet is manufactured and supplied by Trumac Healthcare, a WHO-GMP certified pharmaceutical company in India. This tablet is available for monopoly PCD pharma franchise, wholesale and distributor supply, and third party / contract manufacturing across all Indian states.
Therapeutic Indications
- Oedema due to heart failure, liver cirrhosis or kidney disease
- Oedema in heart failure, liver cirrhosis and nephrotic syndrome
- Hypertension, combined with a thiazide diuretic
Mechanism of Action
Hydroflumethiazide — Hydroflumethiazide inhibits sodium-chloride reabsorption in the distal convoluted tubule, increasing salt and water excretion. With spironolactone, its potassium loss is balanced by potassium retention.
Spironolactone — Blocks aldosterone receptors in the kidney, increasing sodium and water excretion while conserving potassium; thiazide partners add diuresis and offset potassium loss.
Combining these ingredients in one tablet provides complementary action on the target condition and simplifies therapy compared with taking the components separately.
Dosage & Administration
- Dosage of Hydroflumethiazide + Spironolactone Tablet must be individualised by the treating physician according to the patient's age, body weight, indication, disease severity and renal or hepatic function.
- Refer to the approved prescribing information for exact dose, frequency, route and duration of therapy.
- Do not exceed the prescribed dose, and complete the full course as advised.
- Dose adjustment may be required in renal or hepatic impairment, in the elderly and in paediatric patients.
- To be dispensed only against a valid prescription from a registered medical practitioner.
Side Effects
- Electrolyte imbalance (low sodium, potassium changes)
- Dizziness and low blood pressure
- Raised uric acid and gout
- High potassium levels
- Breast enlargement or tenderness
- Menstrual irregularities
Contraindications
- Known hypersensitivity to any component of the formulation
- Anuria or severe renal impairment
- Hyperkalaemia with spironolactone combination
- High blood potassium or Addison's disease
- Severe kidney impairment
Storage
Store below 30 °C in a dry place, protected from light and moisture. Keep in the original packaging until use. Keep out of reach of children. Dispense strictly on a registered medical practitioner's prescription.
From Trumac Healthcare, a pharma franchise company in India, available on a monopoly basis – see the general range products product list (PDF). See our full PCD franchise tablets range. Comparing companies? See the general range PCD companies compared. No franchise fee; minimum first order ₹25,000 – cost and documents.
See the full cardiac tablets range – manufacturer, supplier and PCD franchise: telmisartan, olmesartan, amlodipine, metoprolol, rosuvastatin, atorvastatin, clopidogrel, ticagrelor, trimetazidine and their combinations.
PCD Pharma Franchise & Third Party Manufacturing — Hydroflumethiazide + Spironolactone Tablet
- ✓ Made at WHO-GMP certified partner units — every batch QC released
- ✓ Monopoly PCD franchise rights at district or state level
- ✓ Third party / contract manufacturing under your own brand
- ✓ Wholesale and distributor supply against drug licence + GST
- ✓ Attractive net rates with healthy PTR / PTS margins
- ✓ Dispatch within 48 hours of payment realisation
Composition: Hydroflumethiazide + Spironolactone. It is a fixed-dose combination of thiazide diuretic and potassium-sparing diuretic (aldosterone antagonist), used for oedema due to heart failure, liver cirrhosis or kidney disease and hypertension, combined with a thiazide diuretic. Trumac Healthcare supplies it with complete quality documentation — batch Certificate of Analysis, GMP certificate and statutory invoicing — to PCD franchise partners, stockists, wholesalers and hospital supply chains nationwide.
Hydroflumethiazide + Spironolactone Tablet brings together Hydroflumethiazide (thiazide diuretic) and Spironolactone (potassium-sparing diuretic) in a single fixed-dose formulation.
PCD franchise partners receive monopoly territory rights at district or state level, promotional support including visual aids and sample literature, competitive net rates with healthy PTR/PTS margins, and dispatch within 48 hours of payment realisation. Third party manufacturing of Hydroflumethiazide + Spironolactone Tablet under your own brand name is available subject to minimum order quantity and valid drug licence and GST documentation.
Frequently Asked Questions
Who manufactures Hydroflumethiazide + Spironolactone Tablet in India?
Trumac Healthcare is a supplier of Hydroflumethiazide + Spironolactone Tablet in India; products are made at WHO-GMP certified partner units. We supply pan-India to PCD franchise partners, wholesalers, distributors and hospital chains, with full QC documentation and batch Certificate of Analysis. Contact +91 90416 77932 for net rates and availability.
What is Hydroflumethiazide + Spironolactone Tablet used for?
Hydroflumethiazide + Spironolactone Tablet is used for oedema due to heart failure, liver cirrhosis or kidney disease; oedema in heart failure, liver cirrhosis and nephrotic syndrome; hypertension, combined with a thiazide diuretic. It should be used as advised by a registered medical practitioner.
Is Hydroflumethiazide + Spironolactone Tablet available for PCD pharma franchise on monopoly basis?
Yes. Hydroflumethiazide + Spironolactone Tablet is available for monopoly PCD (Propaganda Cum Distribution) pharma franchise across India, with monopoly rights granted at district or state level. Franchise partners receive promotional support, territory protection, competitive net rates with healthy PTR/PTS margins and dedicated backend support.
Do you offer Hydroflumethiazide + Spironolactone for third party or contract manufacturing?
Yes. Trumac Healthcare undertakes third party manufacturing and contract manufacturing of Hydroflumethiazide + Spironolactone Tablet under your own brand name, subject to minimum order quantity and valid drug licence and GST documentation. Custom pack sizes, carton design and artwork are supported.
Can Hydroflumethiazide + Spironolactone Tablet be supplied on wholesale or distributor basis?
Yes. Beyond PCD franchise, this product is supplied to wholesalers, stockists and distributors at wholesale rates against a valid drug licence and GST registration. Bulk and institutional supply is available on request.
What is the therapeutic class of Hydroflumethiazide + Spironolactone?
Hydroflumethiazide + Spironolactone is a fixed-dose combination of thiazide diuretic and potassium-sparing diuretic (aldosterone antagonist) (therapeutic class: Fixed-Dose Combination — Thiazide diuretic + Potassium-sparing diuretic (aldosterone antagonist)).
What documentation is provided with each supply?
Every batch ships with a Certificate of Analysis (COA), GMP certificate, drug licence copies and statutory invoice. We also support PCD partner documentation including monopoly agreement, rate contract and product list.
How quickly can an order be dispatched?
Routine PCD orders are dispatched within 48 hours of payment realisation, subject to stock availability and your distance from our depot. For monopoly partners we maintain buffer stock against forecasted monthly off-take.
Is a prescription required for Hydroflumethiazide + Spironolactone Tablet?
Yes. This is a prescription medicine and must be used strictly under the supervision of a registered medical practitioner. PCD franchise distribution is through licensed retail pharmacies and hospital supply chains only.
Ready to start your PCD franchise for Hydroflumethiazide + Spironolactone Tablet?
